Novartis Ag (NVS) Other Working Capital Changes (2009 - 2025)

Novartis Ag has disclosed Other Working Capital Changes across 18 years of filings, most recently posting -$67.0 million for Q2 2026.

• In Q2 2026, Other Working Capital Changes fell 1.52% year-over-year to -$67.0 million; the TTM figure through Jun 2026 stood at -$348.0 million (down 7.08% YoY), while the FY2025 annual figure was -$281.0 million, down 7.25% from the prior year.
• Other Working Capital Changes came in at -$67.0 million for Q2 2026 at Novartis Ag, up from -$73.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.3 billion in Q3 2025 to a low of -$2.0 billion in Q1 2022.
• Average Other Working Capital Changes over 5 years is -$196.9 million, with a median of $130.0 million recorded in 2021.
• Year-over-year, Other Working Capital Changes rose 20.0% in 2022 and tumbled 96.88% in 2024.
• Over 5 years, Other Working Capital Changes stood at -$64.0 million in 2022, then changed by 0.0% to -$64.0 million in 2023, then plunged by 96.88% to -$126.0 million in 2024, then declined by 7.14% to -$135.0 million in 2025, then surged by 50.37% to -$67.0 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$67.0 million in Q2 2026, -$73.0 million in Q1 2026, and -$135.0 million in Q4 2025.